Getting the right drug into the right patient

被引：50

作者：

Marshall, A

机构：

来源：

NATURE BIOTECHNOLOGY | 1997年 / 15卷 / 12期

关键词：

D O I：

10.1038/nbt1197-1249

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Pharmacogenomics will help explain why drugs work better in some patients than in others. These tools should be used as early in the drug development process as possible.

引用

页码：1249 / 1252

页数：4

共 4 条

[1]

*DEP HLTH HUM SERV, 1997, GUID IND DRUG MET DR

[2] Apolipoprotein E genotype and gender influence response to tacrine therapy [J].

Farlow, MR ;

Lahiri, DK ;

Poirier, J ;

Davignon, J ;

Hui, S .

APOLIPOPROTEIN E GENOTYPING IN ALZHEIMER'S DISEASE, 1996, 802 :101-110

[3]

POIRER J, 1995, P NATL ACAD SCI USA, V92, P12280

[4] APOE genotyping and response to drug treatment in Alzheimer's disease [J].

Richard, F ;

Helbecque, N ;

Neuman, E ;

Guez, D ;

Levy, R ;

Amouyel, P .

LANCET, 1997, 349 (9051) :539-539

← 1 →